Precision Events | World Conference on Lung Cancer 2026

Precision for Medicine is excited to attend the World Conference on Lung Cancer 2026, from September 12-15 in Seoul, South Korea. WCLC brings together the global thoracic oncology community to share groundbreaking research, explore emerging treatment approaches, and collaborate on improving outcomes for patients with lung cancer and other thoracic malignancies.

As lung cancer programs become increasingly biomarker-driven, sponsors need partners who can connect every stage of development. Precision helps biopharmaceutical companies accelerate the development of targeted therapies, immunotherapies, antibody-drug conjugates, and combination treatment strategies through integrated clinical trial execution, translational research, biomarker and companion diagnostic expertise, specialty laboratory services, clinical logistics, and regulatory expertise.

Book time with our team in Seoul to discuss your development goals and explore solutions tailored to your program.

Precision Experts at WCLC 2026

Harpreet Singh, MD

Chief Medical Officer, Clinical Solutions

(SizeLimitingPyList: [linkedin])
James Cheong

SVP Asia Pacific, Clinical Solutions

(SizeLimitingPyList: [linkedin])
Ying Ping Yeo

VP, Clinical Solutions - Clinical Operations

(SizeLimitingPyList: [linkedin])
Bob Bauer

VP, Operational Strategy, Clinical Solutions

(SizeLimitingPyList: [linkedin])

Related Resources

Whether you're planning an early oncology program, optimizing a biomarker-driven trial, or looking for integrated labs and biospecimen support, our team of experts will be at World Conference on Lung Cancer and ready to connect.

Explore resources

eBook
Dose Optimization: A Strategic Lever in Oncology Drug Development
Download eBook
Whitepaper
Beyond Geography: A Former Regulator’s Perspective on Multiregional Oncology Trials
Download Whitepaper